Advances and Challenges of Stimuli-Responsive Nucleic Acids Delivery System in Gene Therapy

Gene therapy has emerged as a powerful tool to treat various diseases, such as cardiovascular diseases, neurological diseases, ocular diseases and cancer diseases. In 2018, the FDA approved Patisiran (the siRNA therapeutic) for treating amyloidosis. Compared with traditional drugs, gene therapy can...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Meng, Qi, Xianrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220631/
https://www.ncbi.nlm.nih.gov/pubmed/37242692
http://dx.doi.org/10.3390/pharmaceutics15051450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220631/
https://www.ncbi.nlm.nih.gov/pubmed/37242692
http://dx.doi.org/10.3390/pharmaceutics15051450

Ejemplares similares